RAFFA WEALTH MANAGEMENT, LLC’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$212 Sell
1
-6
-86% -$1.18K ﹤0.01% 1257
2026
Q1
$1.37K Buy
7
+2
+40% +$389 ﹤0.01% 862
2025
Q4
$868 Hold
5
﹤0.01% 956
2025
Q3
$953 Hold
5
﹤0.01% 905
2025
Q2
$898 Hold
5
﹤0.01% 895
2025
Q1
$846 Hold
5
﹤0.01% 869
2024
Q4
$754 Sell
5
-13
-72% -$2.02K ﹤0.01% 928
2024
Q3
$2.79K Hold
18
﹤0.01% 546
2024
Q2
$2.46K Hold
18
﹤0.01% 670
2024
Q1
$2.4K Hold
18
﹤0.01% 661
2023
Q4
$2.48K Hold
18
﹤0.01% 552
2023
Q3
$2.19K Hold
18
﹤0.01% 557
2023
Q2
$2.53K Hold
18
﹤0.01% 541
2023
Q1
$2.55K Hold
18
﹤0.01% 547
2022
Q4
$2.82K Hold
18
﹤0.01% 498
2022
Q3
$2.21K Hold
18
﹤0.01% 564
2022
Q2
$2.39K Hold
18
﹤0.01% 563
2022
Q1
$2.46K Hold
18
﹤0.01% 587
2021
Q4
$3.11K Hold
18
﹤0.01% 541
2021
Q3
$2.62K Hold
18
﹤0.01% 541
2021
Q2
$2.38K Hold
18
﹤0.01% 576
2021
Q1
$2.31K Buy
18
+5
+38% +$616 ﹤0.01% 593
2020
Q4
$1.55K Hold
13
﹤0.01% 619
2020
Q3
$1.49K Hold
13
﹤0.01% 564
2020
Q2
$1.48K Hold
13
﹤0.01% 542
2020
Q1
$1.04K Hold
13
﹤0.01% 581
2019
Q4
$1.39K Hold
13
﹤0.01% 500
2019
Q3
$1.39K Buy
+13
New +$1.33K ﹤0.01% 481
2019
Q2
Sell
-13
Closed -$1.17K 901
2019
Q1
$1.17K Hold
13
﹤0.01% 504
2018
Q4
$1.08K Hold
13
﹤0.01% 497
2018
Q3
$1.4K Hold
13
﹤0.01% 465
2018
Q2
$1.43K Hold
13
﹤0.01% 436
2018
Q1
$1.3K Buy
+13
New +$1.33K ﹤0.01% 434

Other funds holding DGX

RAFFA WEALTH MANAGEMENT, LLC's DGX Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC reduced its Quest Diagnostics (DGX) stake by 86% in Q2 2026, selling an estimated $1.18K and leaving 1 share worth $212. The position accounts for ﹤0.01% of the portfolio, ranked #1257.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in DGX in Q1 2018 and has held it in 33 quarters since. The position peaked at $3.11K in Q4 2021. 380 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 1 share of Quest Diagnostics worth $212 as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC sold 6 Quest Diagnostics shares in Q2 2026, an estimated $1.18K.
  • Quest Diagnostics made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #1257 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Quest Diagnostics in Q1 2018 and has held it in 33 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Quest Diagnostics position peaked at $3.11K in Q4 2021.
  • 380 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.